Work

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

Year: 1999

Type: article

Source: American Heart Journal

DOI: 10.1016/s0002-8703(99)70250-4

Authors: Christopher M. O'Connor, Wendy A. Gattis, Barry F. Uretsky, Kirkwood F. Adams, Steven E. McNulty, Steven H. Grossman, William J. McKenna, Faiez Zannad, Karl Swedberg, Mihai Gheorghiade, Robert M. Califf

Institutions: Duke Medical Center, University of North Carolina at Chapel Hill, St George's, University of London, The University of Texas Medical Branch at Galveston

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1977584503

FWCI: 7.927

Cites: 21

Cited by: 517

Related to: 10